cefodizime has been researched along with Gonorrhea in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tapsall, JW | 1 |
| Sakuma, S; Tanaka, M | 1 |
| Tanaka, M | 1 |
| Ando, Y; Ikuyama, T; Kurashima, M; Matsumoto, T; Muratani, T; Sato, Y; Shimokawa, H; Takahashi, K; Yanai, S; Yokoo, D | 2 |
| Boot, JM; Heeres-Weststrate, PL; Knapp, JS; Michel, MF; Schalla, WO; Stolz, E; van der Willigen, AH; van Klingeren, B; Wagenvoort, JH | 1 |
2 review(s) available for cefodizime and Gonorrhea
| Article | Year |
|---|---|
[Gonococcal infection].
Topics: 4-Quinolones; Anti-Infective Agents; Cefotaxime; Diagnosis, Differential; Female; Gonorrhea; Humans; Male; Molecular Diagnostic Techniques; Neisseria gonorrhoeae; Pharyngitis; Prognosis; Urethritis; Uterine Cervicitis | 2003 |
[Pharyngeal gonococcal infections].
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Female; Gonorrhea; Humans; Japan; Male; Neisseria gonorrhoeae; Pharyngitis; Sexual Behavior; Sexually Transmitted Diseases | 2004 |
2 trial(s) available for cefodizime and Gonorrhea
| Article | Year |
|---|---|
Single dose of cefodizime completely eradicated multidrug-resistant strain of Neisseria gonorrhoeae in urethritis and uterine cervicitis.
Topics: Anti-Bacterial Agents; Cefotaxime; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Urethritis; Uterine Cervicitis | 2006 |
Randomized comparative study of 0.5 and 1 g of cefodizime (HR 221) versus 1 g of cefotaxime for acute uncomplicated urogenital gonorrhea.
Topics: Cefotaxime; Chlamydia trachomatis; Drug Evaluation; Female; Gonorrhea; Humans; Injections, Intramuscular; Male; Random Allocation | 1988 |
2 other study(ies) available for cefodizime and Gonorrhea
| Article | Year |
|---|---|
Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Topics: Anti-Bacterial Agents; Asia, Southeastern; Australia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Dose-Response Relationship, Drug; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pacific Islands; Treatment Failure; World Health Organization | 2009 |
Multiple doses of cefodizime are necessary for the treatment of Neisseria gonorrhoeae pharyngeal infection.
Topics: Anti-Bacterial Agents; Cefotaxime; Drug Resistance; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharyngeal Diseases | 2006 |